Catastrophic drug coverage: utilization insights from the Ontario Trillium Drug Program
M Tadrous, S Greaves, D Martins… - … Open Access Journal, 2018 - cmajopen.ca
Background: Catastrophic drug coverage programs help those with high drug-costs to
reduce the burden of out-of-pocket expenses. We set out to measure changes in utilization …
reduce the burden of out-of-pocket expenses. We set out to measure changes in utilization …
[PDF][PDF] Catastrophic Coverage in the Medicare Part D Drug Benefit: Which Beneficiaries Need It and How Much Are They Spending?
ABSTRACT ISSUE: Between 2013 and 2017, spending on Medicare Part D catastrophic
coverage more than doubled, reaching over $59 billion in 2017. In the catastrophic phase …
coverage more than doubled, reaching over $59 billion in 2017. In the catastrophic phase …
Medicare beneficiaries face growing out-of-pocket burden for specialty drugs while in catastrophic coverage phase
The Affordable Care Act (ACA) includes provisions to reduce Medicare beneficiaries' out-of-
pocket spending for prescription drugs by gradually closing the coverage gap between the …
pocket spending for prescription drugs by gradually closing the coverage gap between the …
[PDF][PDF] High-price drugs are increasing federal payments for Medicare Part D catastrophic coverage
D Levinson, I General - General HaHSOotI, ed, 2017 - oversight.gov
Moreover, 10 high-price drugs accounted for nearly one-third of all drug spending for
catastrophic coverage in 2015. Most of these drugs cost thousands of dollars per month …
catastrophic coverage in 2015. Most of these drugs cost thousands of dollars per month …
[HTML][HTML] Do reimbursement recommendations by the Canadian Agency for Drugs and Technology in Health translate into coverage decisions for orphan drugs in the …
AM Fontrier, P Kanavos - Value in Health, 2023 - Elsevier
Objectives Unlike other high-income countries, Canada has no national policy for drugs
treating rare diseases (orphan drugs). Nevertheless, in 2022, the Canadian government …
treating rare diseases (orphan drugs). Nevertheless, in 2022, the Canadian government …
[HTML][HTML] Addressing the authorization of orphan drugs will not fix reimbursement problems: The elephant is still in the room
M Embrett - Canadian Pharmacists Journal: CPJ, 2013 - ncbi.nlm.nih.gov
The October 3, 2012, orphan drug initiative announced by the Federal Ministry of Health
aimed at improving availability of information about, and authorization of, orphan drugs may …
aimed at improving availability of information about, and authorization of, orphan drugs may …
Part D coverage gap reform: Trends in drug use and expenditures
Objectives This study analyzed annual trends in the distribution of beneficiaries entering
each benefit phase and the utilization of and expenditures for prescription drugs among …
each benefit phase and the utilization of and expenditures for prescription drugs among …
[BOOK][B] National Catastrophic Drug Insurance Revisited: Who Would Benefit from Senator Kirby's Recommendations?
Abstract The recent 'Romanow'and 'Kirby'inquiries into the Canadian health care system
recommended a publicly funded catastrophic prescription drug insurance program to protect …
recommended a publicly funded catastrophic prescription drug insurance program to protect …
Stitching the gaps in the Canadian public drug coverage patchwork? A review of provincial pharmacare policy changes from 2000 to 2010
OBJECTIVES: To describe recent changes and identify emergent trends in public drug
benefit policies in Canada from 2000 to 2010. METHODS: For each province, we tracked …
benefit policies in Canada from 2000 to 2010. METHODS: For each province, we tracked …
Catastrophic drug coverage in Canada
KF Azores - Healthy Dialogue, 2013 - yujhs.journals.yorku.ca
There is currently no nationwide catastrophic drug coverage in Canada, and this creates
many inequities with regards to the costs and accessibility of out-of-hospital (outpatient) …
many inequities with regards to the costs and accessibility of out-of-hospital (outpatient) …